Cannabis abuse as a risk factor for depressive symptoms
- PMID: 11729021
- DOI: 10.1176/appi.ajp.158.12.2033
Cannabis abuse as a risk factor for depressive symptoms
Abstract
Objective: This study sought to estimate the degree to which cannabis abuse is a risk factor for depressive symptoms rather than an effort to self-medicate depression.
Method: Participants (N=1,920) in the 1980 Baltimore Epidemiologic Catchment Area (ECA) study who were reassessed between 1994 and 1996 as part of a follow-up study provided the data. The analysis focused on two cohorts: those who reported no depressive symptoms at baseline (N=849) and those with no diagnosis of cannabis abuse at baseline (N=1,837). Symptoms of depression, cannabis abuse, and other psychiatric disorders were assessed with the Diagnostic Interview Schedule.
Results: In participants with no baseline depressive symptoms, those with a diagnosis of cannabis abuse at baseline were four times more likely than those with no cannabis abuse diagnosis to have depressive symptoms at the follow-up assessment, after adjusting for age, gender, antisocial symptoms, and other baseline covariates. In particular, these participants were more likely to have experienced suicidal ideation and anhedonia during the follow-up period. Among the participants who had no diagnosis of cannabis abuse at baseline, depressive symptoms at baseline failed to significantly predict cannabis abuse at the follow-up assessment.
Conclusions: Further research is needed to identify characteristics of individuals who abuse cannabis that account for their higher risk of depression to estimate the degree of impairment resulting from their depression.
Comment in
-
Problems with odds ratios.Am J Psychiatry. 2003 Jan;160(1):190-1; author reply 191. doi: 10.1176/appi.ajp.160.1.190-a. Am J Psychiatry. 2003. PMID: 12505837 No abstract available.
-
Problems with odds ratios.Am J Psychiatry. 2003 Jan;160(1):191; author reply 191. doi: 10.1176/appi.ajp.160.1.191. Am J Psychiatry. 2003. PMID: 12505840 No abstract available.
Similar articles
-
Subclinical depressive symptoms and continued cannabis use: predictors of negative outcomes in first episode psychosis.PLoS One. 2015 Apr 15;10(4):e0123707. doi: 10.1371/journal.pone.0123707. eCollection 2015. PLoS One. 2015. PMID: 25875862 Free PMC article.
-
Cannabis use expectancies mediate the relation between depressive symptoms and cannabis use among cannabis-dependent veterans.J Addict Med. 2014 Mar-Apr;8(2):130-6. doi: 10.1097/ADM.0000000000000010. J Addict Med. 2014. PMID: 24365805
-
Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.Aust N Z J Psychiatry. 2000 Jun;34(3):468-75. doi: 10.1080/j.1440-1614.2000.00736.x. Aust N Z J Psychiatry. 2000. PMID: 10881971
-
[Cannabis abuse in patients with psychiatric disorders: an update to old evidence].Braz J Psychiatry. 2010 May;32 Suppl 1:S41-5. Braz J Psychiatry. 2010. PMID: 20512269 Review. Portuguese.
-
[Cannabis and mood].Braz J Psychiatry. 2010 Jun;32(2):173-80. doi: 10.1590/s1516-44462010000200014. Braz J Psychiatry. 2010. PMID: 20658056 Review. Portuguese.
Cited by
-
Cannabis use and mood disorders: a systematic review.Front Public Health. 2024 Apr 9;12:1346207. doi: 10.3389/fpubh.2024.1346207. eCollection 2024. Front Public Health. 2024. PMID: 38655516 Free PMC article.
-
Cannabinoids and the Endocannabinoid System in Early SARS-CoV-2 Infection and Long COVID-19-A Scoping Review.J Clin Med. 2023 Dec 30;13(1):227. doi: 10.3390/jcm13010227. J Clin Med. 2023. PMID: 38202234 Free PMC article. Review.
-
Clinical Characteristics, Support System, and Personality Differences of Cannabis and Stimulant Users in South Korea.Psychiatry Investig. 2023 Oct;20(10):921-929. doi: 10.30773/pi.2023.0029. Epub 2023 Oct 24. Psychiatry Investig. 2023. PMID: 37899215 Free PMC article.
-
Increased cannabis intake during the COVID-19 pandemic is associated with worsening of depression symptoms in people with PTSD.BMC Psychiatry. 2022 Aug 17;22(1):554. doi: 10.1186/s12888-022-04185-7. BMC Psychiatry. 2022. PMID: 35978287 Free PMC article.
-
Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence.Int J Mol Sci. 2022 May 15;23(10):5526. doi: 10.3390/ijms23105526. Int J Mol Sci. 2022. PMID: 35628337 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical